Llwytho...
Targeting NAMPT as a therapeutic strategy against stroke
Stroke is the second and the leading most common cause of death in the world and China, respectively, but with few effective therapies. Nicotinamide phosphoribosyltransferase (NAMPT) is the rate-limiting enzyme for nicotinamide adenine dinucleotide (NAD) salvage synthesis in mammals, thereby influen...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Stroke Vasc Neurol |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BMJ Publishing Group
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6613878/ https://ncbi.nlm.nih.gov/pubmed/31338216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/svn-2018-000199 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|